PF-Atlas › Mechanisms › Lipid nanoparticle platform delivers therapeutic mRNA specifically to lung epithelium
Lipid nanoparticle platform delivers therapeutic mRNA specifically to lung epithelium in IPF
Mechanism of action · idiopathic pulmonary fibrosis
Overview
Lipid nanoparticle platform delivers therapeutic mRNA specifically to lung epithelium is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 0 clinical trials acting through this mechanism.
Drugs targeting Lipid nanoparticle platform delivers therapeutic mRNA specifically to lung epithelium
Therapies
Medical disclaimer. This is a research summary, not medical advice.